Orgenesis Inc. Average Days of Payables

Average Days of Payables of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Average Days of Payables growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Average Days of Payables for 2020 was 37.59 (a -73.99% decrease from previous year)
  • Annual Average Days of Payables for 2019 was 144.53 (a 35.91% increase from previous year)
  • Annual Average Days of Payables for 2018 was 106.34 (a -17.1% decrease from previous year)
  • Twelve month Average Days of Payables ending September 29, 2021 was 15.27 (a -43.82% decrease compared to previous quarter)
  • Twelve month trailing Average Days of Payables decreased by -59.38% year-over-year
Trailing Average Days of Payables for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
15.27 27.18 44.08 37.59
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Average Days of Payables of Orgenesis Inc.

Most recent Average Days of Payablesof ORGS including historical data for past 10 years.

Interactive Chart of Average Days of Payables of Orgenesis Inc.

Orgenesis Inc. Average Days of Payables for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 37.59
2019 144.53
2018 106.34
2017 167.13
2016 179.18
2015 326.9
2014 0.0
2013 0.0
2012 0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.